Skip to content

The brain-heart axis mechanism of insomnia and cardiovascular diseases

The brain-heart axis mechanism of insomnia and cardiovascular diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112917
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Group without insomnia in coronary heart disease:Na
Group with insomnia in coronary heart disease:Insomnia

Sponsors

Guabgzhou First People‘s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Gender is not limited, age 50-70 years old. 2. Patients in the coronary heart disease group must have a clear diagnosis of coronary atherosclerotic heart disease, including previous myocardial infarction, confirmed by coronary angiography or evidence of percutaneous coronary intervention (PCI)/bypass surgery, and the condition must be stable (no active acute coronary syndrome). 3. Patients in the coronary heart disease with insomnia group must meet the clinical diagnostic criteria for insomnia (such as the International Classification of Sleep Disorders, 3rd Edition (ICSD-3) or the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for insomnia disorder). 4. All subjects must provide informed consent and voluntarily participate in the study. Coronary heart disease patients must have good compliance and be willing to cooperate in completing questionnaires and imaging examinations.

Exclusion criteria

Exclusion criteria: 1. Patients with other conditions that may significantly affect sleep or cardiovascular function are excluded. 2. Patients who have used drugs that may affect the central nervous system within the last three months are excluded, including excessive use of benzodiazepine hypnotics and the adjustment period of antidepressants. 3. Patients with contraindications for magnetic resonance imaging (MRI) are excluded. 4. Patients with other serious physical diseases are excluded.

Design outcomes

Primary

MeasureTime frame
Heart Rate Variability (HRV)?;Insomnia Severity (Pittsburgh Sleep Quality Index (PSQI) Score and Insomnia Severity Index (ISI)Score)?;fMRI-based Functional Brain Connectivity??;

Countries

China

Contacts

Public ContactYanlu Ying

Guabgzhou First People‘s Hospital

eyyingyanlu@scut.edu.cn+86 15018467251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026